Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.
Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, Park A, Yang J, Suresh S, Bizhanova A, Gupta A, Bolukbasi MF, Walsh S, Bogorad RL, Gao G, Weng Z, Dong Y, Koteliansky V, Wolfe SA, Langer R, Xue W, Anderson DG
Nat Biotechnol. 2016 Feb 1. doi: 10.1038/nbt.3471.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
73451J7AAV-HDR Fah.2J7AAV-HDR U6sgFah.2 template2 to repair Fah mutation
73452J8AAV-HDR Ctnnb1.1J8AAV-HDR U6sgCtnnb1.1 template

Antibodies from Article